Phosphodiesterase Type-5 Inhibitor Therapy in Sickle Cell People With Pulmonary Hypertension
NCT03572036
·
clinicaltrials.gov ↗
COMPLETED
Status
38
Enrollment
NIH
Sponsor class
Conditions
Pulmonary Hypertension
Sickle Cell Disease
Sponsor
National Heart, Lung, and Blood Institute (NHLBI)